The beginning of 2020 witnessed key projects promoting the cooperation between 
Guangdong and Macao. On January 3, Guangzhou Pharmaceutical Group (Macau) 
International Development Co., Ltd. (hereunder referred to as "the company") 
was established in Macao. Ho Lat Seng, Chief Executive of the Macao Special 
Administrative Region, wrote a congratulatory letter for its contribution to 
the industrial diversification and new momentum, and thus a moderately 
diversified economic development in Macao.  

The company is established by Guangzhou Pharmaceutical Holdings Limited (GPHL) 
in cooperation with Guangdong Namyue Group, Guangdong's leading enterprise in 
Macao and True Point Global Limited, a Macao enterprise. Positioned as a 
platform for GPHL's international business, it is committed to being a new 
growth pole with international competitiveness to take a lead in the 
Guangdong-Hong Kong-Macao Greater Bay Area while covering the Southeast Asia 
and Portuguese-speaking countries. It aims to deepen the pharmaceutical 
cooperation in the Area and promote the moderately diversified economic 
development of Macao and accelerate the internationalization layout of GPHL. 

Li Chuyuan, Chairman of GPHL, said that the shareholding rights structure of 
the company, while contributing to the integrated development of companies from 
both Guangdong and Macao, is beneficial to promote local employment and the 
diversified development of industries in Macao.  

According to the planning, the international headquarters of GPHL in Macao will 
promote the formation of industrial alliance under the guidance of "one 
country, two systems", "one company, two places" and "one product, two selling 
markets". "Two systems" help to accelerate the GPHL's going-global strategy 
with institutional strengths. With its base in Guangzhou, and its international 
headquarters in Macao, it can better exploit the resource advantages in these 
"two places". It will also allow GPHL to compete better in both domestic and 
international markets. 

GPHL has developed a '1-2-4-6' strategy for its international headquarters in 
Macao, which includes one mission, two targets, four aspects and six measures. 
The mission is to support Macao's moderately diversified economic development 
by facilitating development and innovation in the local Traditional Chinese 
Medicine (TCM) industry. The two targets are to make Macao a world-class 
international pharmaceutical industrial base, and to play a leading role in 
expanding the hundred-billion-yuan industrial scale in Macao (and Hengqin) 
through four aspects, which are branding, technology, culture and experience; 
six measures will be taken, arranging from product lines, operations, 
strategies, channels, industrial chains and subjects.  

For future development of its international headquarters, GPHL also established 
Guangzhou Pharmaceutical (Hengqin) Medicine Industrial Park Co., Ltd. in the 
TCM Science and Technology Industrial Park of Co-operation between Guangdong 
and Macao (GMTCM Park). Serving as a platform for pharmaceutical R&D and 
industrialization, it will introduce new projects including R&D, pharmaceutical 
supply chain, Chinese Medicine extraction, which will help GPHL involve into a 
world-class enterprise.  

Source: Guangzhou Pharmaceutical Group (Macau) International Development Co., 
Ltd.

Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=355038

   Caption: Leaders and guests attending the opening ceremony